Olivier van der Rest – Startup Investor Profile

Olivier van der Rest is an angel investor with a track record of professional leadership. He recently invested in Novadip Biosciences as part of their Series B – II, collaborating with co-investors such as CR-CP Life Science Fund, Investsud, and New Science Ventures. Olivier van der Rest’s investment focus areas include Technology Vendors, Corporate Strategy, Corporate Venture Capital, and Venture Capital. His investment check size is not specified. His geographical preference is not explicitly mentioned. The previous investments in Novadip Biosciences reflect his commitment to supporting promising companies. Olivier van der Rest’s partnership and collaboration styles are not detailed in the available information.

Location:

Country: Belgium

Investment Regions: EU

Investment Stages: pre-seed, seed

Website:

AI Reasoning: CB Insights and multiple press sources show Olivier van der Rest’s most recent investment was in Novadip Biosciences as part of a Series B on November 3-4, 2022. Calculating from that date to the reference point (more than 12 months? less than 6 months?), the last investment occurred 24 months earlier. However, according to the rules: ‘very-active’ = last known investment <6 months. The data shows last investment was on Nov 4, 2022 which is 24 months prior, which should map to ‘low-active’. But cross-check: CB Insights lists Nov 04, 2022. From that to the evaluation date equals 24 months; therefore the correct tag is ‘low-active’.[/evc_normalize]

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.